PATENT CLAIM ANALYSIS

Application Number: 15972953
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "197110"]

Abstract:
An immunogenic composition having 13 distinct polysaccharide-protein conjugates and optionally, an aluminum-based adjuvant, is described. Each conjugate contains a capsular polysaccharide prepared from a different serotype of  Streptococcus pneumoniae  (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) conjugated to a carrier protein. The immunogenic composition, formulated as a vaccine, increases coverage against pneumococcal disease in infants and young children globally, and provides coverage for serotypes 6A and 19A that is not dependent on the limitations of serogroup cross-protection.

Claim (Index 3):
The process of  claim 1 , wherein step (b) is effected by reductive amination.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 93.0
- Lexical Diversity: 1.41892
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14322057', '13439111', '12357853', '15042189', '11644095']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8153580981976684
- 35 USC 102 Novelty (BERT): 0.574551602977619
- Combined Prediction Score: 0.7912774486756634
- Mean Citation Score: 589.1149280000002
- Max Citation Score: 591.4125
- Similarity Product: 334.5669126637281

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test